Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 02 04:00PM ET
13.21
Dollar change
+0.58
Percentage change
4.59
%
IndexRUT P/E- EPS (ttm)-0.93 Insider Own28.35% Shs Outstand67.43M Perf Week8.63%
Market Cap890.75M Forward P/E- EPS next Y-1.10 Insider Trans1.33% Shs Float48.31M Perf Month-6.84%
Income-23.91M PEG- EPS next Q-0.22 Inst Own51.77% Short Float14.78% Perf Quarter22.88%
Sales8.84M P/S100.76 EPS this Y45.69% Inst Trans-8.46% Short Ratio8.82 Perf Half Y-8.26%
Book/sh5.06 P/B2.61 EPS next Y-19.61% ROA-27.07% Short Interest7.14M Perf Year389.26%
Cash/sh4.34 P/C3.04 EPS next 5Y- ROE-29.53% 52W Range2.20 - 19.05 Perf YTD228.61%
Dividend Est.- P/FCF- EPS past 5Y-7.69% ROI-6.95% 52W High-30.66% Beta1.45
Dividend TTM- Quick Ratio27.73 Sales past 5Y- Gross Margin27.13% 52W Low500.18% ATR (14)0.93
Dividend Ex-Date- Current Ratio27.73 EPS Y/Y TTM-1350.47% Oper. Margin-346.50% RSI (14)47.28 Volatility6.68% 6.92%
Employees119 Debt/Eq0.01 Sales Y/Y TTM-19.63% Profit Margin-270.46% Recom1.00 Target Price22.62
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q-983.95% Payout- Rel Volume1.61 Prev Close12.63
Sales Surprise186.65% EPS Surprise12.49% Sales Q/Q-74.50% EarningsAug 12 AMC Avg Volume809.95K Price13.21
SMA20-4.85% SMA50-4.00% SMA20013.18% Trades Volume1,289,926 Change4.59%
Date Action Analyst Rating Change Price Target Change
Oct-01-24Initiated Wedbush Outperform $25
Sep-25-24Initiated Truist Buy $21
Jul-25-24Initiated BofA Securities Buy $24
May-09-24Initiated Cantor Fitzgerald Overweight
Sep-30-24 07:00AM
Sep-10-24 07:00AM
Sep-05-24 07:00AM
Aug-28-24 07:00AM
Aug-13-24 09:40AM
04:35PM Loading…
Aug-12-24 04:35PM
04:05PM
Jul-30-24 07:00AM
Jul-25-24 06:15AM
Jul-22-24 07:00AM
Jul-16-24 09:55AM
Jun-12-24 07:00AM
Jun-11-24 07:00AM
Jun-10-24 04:10PM
May-24-24 08:01AM
07:00AM Loading…
May-20-24 07:00AM
May-15-24 07:49AM
07:13AM
07:00AM
May-03-24 07:00AM
03:04AM
May-02-24 07:00AM
Apr-30-24 07:00AM
07:00AM
Apr-08-24 08:00AM
Mar-30-24 05:31AM
Mar-28-24 07:30AM
Mar-19-24 10:39AM
Mar-18-24 08:00AM
Mar-11-24 08:00AM
08:00AM Loading…
Mar-05-24 08:00AM
Mar-04-24 09:45AM
Feb-26-24 08:00AM
Feb-20-24 06:30AM
Feb-12-24 08:00AM
Feb-08-24 10:00AM
Feb-01-24 08:00AM
Jan-22-24 04:05PM
Jan-18-24 07:00AM
Jan-17-24 04:05PM
08:00AM
Jan-09-24 08:00AM
08:00AM
Jan-05-24 08:00AM
Jan-02-24 08:00AM
Dec-12-23 08:00AM
Dec-07-23 08:00AM
Nov-28-23 08:00AM
Nov-27-23 08:00AM
Nov-16-23 08:00AM
Nov-14-23 04:25PM
Nov-08-23 08:00AM
Oct-16-23 08:00AM
Oct-10-23 08:00AM
Oct-05-23 04:05PM
Sep-12-23 08:00AM
Sep-11-23 08:00AM
Aug-30-23 08:17AM
Aug-28-23 08:00AM
Aug-11-23 09:15AM
08:11AM
08:05AM
08:00AM
Aug-09-23 08:05AM
Jun-27-23 08:00AM
Jun-21-23 08:00AM
Jun-16-23 08:00AM
Jun-08-23 08:00AM
May-28-23 06:36PM
May-24-23 08:10AM
May-16-23 05:02AM
May-15-23 08:22PM
05:35PM
04:49PM
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1983 and is headquartered in Seattle, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mark AustinaffiliateSep 12 '24Proposed Sale15.802,50039,500Sep 12 02:44 PM
Hunt Jonathan RobertChief Financial OfficerJun 17 '24Buy9.811,80017,66735,971Jun 18 07:48 AM
Woods Lori ADirectorJun 14 '24Buy10.904,58749,990159,985Jun 18 07:45 AM
Spoor Johan M.CEOJun 13 '24Buy1.17100,000117,430137,572Jun 13 05:19 PM
Woods Lori ADirectorJun 03 '24Buy1.4634,24649,9921,553,984Jun 04 04:02 PM
Hunt Jonathan RobertChief Financial OfficerMay 31 '24Buy1.4025,00635,007341,716Jun 03 04:05 PM
Williamson Robert F IIIDirectorMay 31 '24Buy1.3855,00075,900423,792Jun 03 04:01 PM
Williamson Robert F IIIDirectorMay 29 '24Buy1.3330,03140,014368,792May 30 04:05 PM
Austin Mark JohnVP Finance/Prin Fin&Acct OfficApr 23 '24Option Exercise0.3630,00010,80084,030Apr 24 04:35 PM
Lantheus Alpha Therapy, LLC10% OwnerMar 06 '24Buy0.9560,431,03957,409,487116,773,394Mar 08 11:24 AM
Williamson Robert F IIIDirectorJan 30 '24Buy0.71127,20690,710338,761Feb 01 04:53 PM
Williamson Robert F IIIDirectorJan 26 '24Buy0.56110,61362,304186,289Jan 30 04:57 PM
Williamson Robert F IIIDirectorJan 29 '24Buy0.6425,26616,170211,555Jan 30 04:57 PM
Puhlmann MarkusChief Medical OfficerJan 24 '24Buy0.50280,000139,8881,375,425Jan 26 05:40 PM
Williamson Robert F IIIDirectorJan 24 '24Buy0.4929,86214,63253,542Jan 26 05:38 PM
Williamson Robert F IIIDirectorJan 25 '24Buy0.4922,13410,84675,676Jan 26 05:38 PM
Williamson Robert F IIIDirectorDec 21 '23Buy0.333,6631,2033,663Dec 26 05:00 PM
Hunt Jonathan RobertChief Financial OfficerDec 18 '23Buy0.26125,00032,338316,710Dec 19 07:11 PM
Williamson Robert F IIIDirectorDec 19 '23Buy0.3213,6804,37823,680Dec 19 07:10 PM
Williamson Robert F IIIDirectorDec 18 '23Buy0.2610,0002,60010,000Dec 19 07:10 PM
Puhlmann MarkusChief Medical OfficerDec 19 '23Buy0.34400,000137,0001,095,425Dec 19 07:09 PM
Puhlmann MarkusChief Medical OfficerDec 15 '23Buy0.27135,00636,276635,006Dec 19 07:09 PM
Puhlmann MarkusChief Medical OfficerDec 18 '23Buy0.2660,41915,461695,425Dec 19 07:09 PM
Woods Lori ADirectorDec 15 '23Buy0.27152,96241,2841,519,738Dec 18 04:16 PM
Woods Lori ADirectorDec 14 '23Buy0.2732,2388,7041,366,776Dec 18 04:16 PM